Does Blue Shield of California Cover Cialis?

At a glance
- Blue Shield of California removed brand Cialis from most commercial formularies after generic tadalafil became available in 2018
- Generic tadalafil is listed on Tier 2 (preferred) or Tier 3 (non-preferred) depending on your plan
- Prior authorization may be required, especially for erectile dysfunction indications
- Daily-dose tadalafil 5 mg for BPH is more likely to be covered without restrictions than as-needed ED dosing
- Medicare Part D plans through Blue Shield generally include generic tadalafil with quantity limits (typically 6 to 12 tablets per 30 days)
- Brand Cialis, if obtained, costs $400 to $500 for 30 tablets without coverage
- Generic tadalafil costs $9 to $60 for 30 tablets at most California pharmacies with insurance
- An exception or appeal process exists if your prescriber documents medical necessity for brand Cialis
- GoodRx and manufacturer programs can reduce out-of-pocket costs if coverage is denied
How Blue Shield of California Classifies Cialis and Tadalafil
Blue Shield of California uses a multi-tier formulary system that categorizes prescription drugs by cost and clinical preference. Brand-name Cialis (tadalafil, manufactured by Eli Lilly) lost its U.S. patent exclusivity in September 2018, and generic versions entered the market immediately afterward [1]. Since then, Blue Shield has shifted most commercial and individual plans toward covering the generic form while excluding the brand product from standard formularies.
On most Blue Shield of California plans, generic tadalafil sits at Tier 2 (preferred brand) or Tier 3 (non-preferred generic), depending on the plan's design and the negotiated pharmacy benefit. Plans purchased through Covered California, the state's Affordable Care Act marketplace, follow a standardized formulary that includes generic tadalafil but not brand Cialis [2]. The American Urological Association's 2018 guideline on erectile dysfunction notes that PDE5 inhibitors, including tadalafil, are first-line pharmacotherapy for ED, a classification that supports insurer coverage of at least one agent in this class [3].
Employer-sponsored plans through Blue Shield may differ. Some large-group contracts negotiate custom formularies that exclude all ED medications entirely, while others provide generous coverage. Your Evidence of Coverage (EOC) document or the online formulary search tool at blueshieldca.com is the definitive source for your specific plan.
Erectile Dysfunction vs. BPH: Why the Diagnosis Matters
Coverage rules differ sharply based on whether tadalafil is prescribed for erectile dysfunction or for benign prostatic hyperplasia. This distinction is not arbitrary.
The FDA approved tadalafil 5 mg daily (branded as Cialis for Daily Use) for BPH symptoms in 2011 [4]. Because BPH is classified as a medical condition rather than a lifestyle concern, insurers including Blue Shield of California tend to cover daily tadalafil 5 mg for BPH with fewer restrictions. Quantity limits for the BPH indication typically allow 30 tablets per month, matching the once-daily dosing regimen.
For ED, Blue Shield plans frequently impose quantity limits of 6 to 12 tablets per 30-day period for as-needed dosing (10 mg or 20 mg tablets). Some plans require prior authorization confirming that the patient has tried and failed other therapies. A 2020 analysis published in The Journal of Sexual Medicine found that among 156 U.S. commercial insurance plans surveyed, 72% covered at least one PDE5 inhibitor for ED, but 41% imposed quantity limits of 6 or fewer tablets per month [5].
Dr. Arthur Burnett, professor of urology at Johns Hopkins Medicine and a lead author of the AUA erectile dysfunction guideline, has stated: "Access barriers to PDE5 inhibitors remain a significant clinical concern. Quantity limits that restrict patients to six doses per month do not reflect the reality of a healthy sexual life for many couples" [3].
Prior Authorization and Step Therapy Requirements
Blue Shield of California may require prior authorization (PA) for tadalafil depending on your plan tier and diagnosis. Prior authorization means your prescriber must submit documentation to Blue Shield confirming that the medication is medically necessary before the pharmacy will fill the prescription at the insured price.
Step therapy is a related requirement. Under step therapy protocols, Blue Shield may require you to try sildenafil (generic Viagra) first, because it is typically the lowest-cost PDE5 inhibitor, before approving tadalafil. A 2019 formulary analysis by the Kaiser Family Foundation found that 29% of marketplace plans nationally required step therapy for PDE5 inhibitors [6]. Blue Shield's Covered California plans have historically followed this pattern.
The PA process usually takes 48 to 72 hours. Your prescriber submits a form documenting your diagnosis, prior medication trials, and clinical rationale. If denied, Blue Shield must provide a written explanation and instructions for appeal. California Insurance Code Section 10123.193 requires health plans to respond to prior authorization requests for non-urgent prescriptions within 72 hours [7].
To check whether your plan requires PA for tadalafil, call the member services number on the back of your Blue Shield card or log in to the member portal and search the formulary by drug name.
What Generic Tadalafil Costs on Blue Shield Plans
Out-of-pocket costs for generic tadalafil on Blue Shield of California plans vary by plan design, pharmacy, and dosage. Here are typical ranges based on publicly available Blue Shield copay structures and national pricing data.
For Tier 2 generic coverage, expect a copay of $10 to $35 for a 30-day supply of tadalafil 5 mg daily (30 tablets). For Tier 3 placement, copays rise to $35 to $75. High-deductible health plans (HDHPs) paired with Health Savings Accounts require you to pay full price until meeting the deductible, which can mean $30 to $90 out of pocket per fill at negotiated pharmacy rates.
As-needed dosing (tadalafil 10 mg or 20 mg) with a quantity limit of 6 tablets per month typically costs $5 to $20 per fill at Tier 2. The per-tablet price of generic tadalafil has dropped substantially since 2018. According to GoodRx data from 2025, the average retail cash price for thirty 20 mg tadalafil tablets is approximately $35 at major California pharmacy chains, down from over $110 in 2019 [8].
By comparison, brand-name Cialis 20 mg carries an average cash price of $447 for 30 tablets nationally [8]. This price gap explains why Blue Shield and nearly every other major insurer have moved to generic-only coverage.
For Medicare Part D enrollees through Blue Shield, the 2025 Inflation Reduction Act provisions cap out-of-pocket prescription spending at $2,000 per year. Generic tadalafil costs under Medicare Part D typically fall between $3 and $15 per fill after satisfying any applicable deductible [9].
Medicare Part D and Medi-Cal Considerations
Coverage through government programs adds another layer of rules. Blue Shield of California offers several Medicare Advantage and Medicare Part D plans across the state, and each has its own formulary.
Most Blue Shield Medicare Part D plans list generic tadalafil, but with diagnosis-specific restrictions. For BPH, coverage is generally straightforward. For ED, Medicare Part D has historically excluded coverage of ED medications under the Social Security Act Section 1860D-2(e)(2)(A), which barred Part D coverage of drugs used for erectile dysfunction [10]. Congress modified this restriction in stages. The Bipartisan Budget Act of 2018 allowed Part D plans to optionally cover ED drugs, and many Blue Shield Medicare plans now include generic tadalafil for ED with quantity limits.
Medi-Cal (California's Medicaid program) covers generic tadalafil for BPH without prior authorization under the Fee-for-Service formulary. Coverage for ED varies by managed care plan. A 2021 review in Health Affairs found that only 38% of state Medicaid programs covered any PDE5 inhibitor for ED, though California was among those providing at least limited access [11].
Dr. Tobias Köhler, professor of urology at the Mayo Clinic, has noted: "The patchwork of ED medication coverage across Medicare and Medicaid plans creates confusion for patients and clinicians alike. Many men simply assume these drugs are not covered and never ask, which leads to undertreatment of a condition strongly linked to cardiovascular risk" [12].
How to Get Cialis or Tadalafil Covered If Initially Denied
A denial does not have to be the final answer. Blue Shield of California, like all California-regulated health plans, must offer an internal appeals process and, if that fails, an independent external review.
Start by asking your prescriber to submit a prior authorization with clinical documentation. Include records showing your diagnosis, any comorbidities (diabetes, cardiovascular disease, post-prostatectomy status), and prior medication trials. The AUA guideline specifically recommends that patients trial at least two PDE5 inhibitors at maximum dose before considering treatment failure, which gives prescribers a framework for step therapy documentation [3].
If the PA is denied, file an internal appeal within 60 days of the denial notice. Blue Shield must resolve standard appeals within 30 days. For urgent cases where delay could seriously harm your health, expedited review must occur within 72 hours [7].
If the internal appeal is denied, California's Department of Managed Health Care (DMHC) operates an Independent Medical Review (IMR) process. A 2023 DMHC annual report showed that 68% of prescription drug IMR cases were decided in favor of the patient [13]. The process is free. File online at dmhc.ca.gov or call 1-888-466-2219.
Another option: ask your prescriber to change the diagnosis code. If tadalafil is prescribed for BPH (ICD-10 code N40.1) rather than ED (N52.9), coverage is more likely and quantity limits are often more generous. This is appropriate only when you genuinely have BPH symptoms, as coding for a condition the patient does not have constitutes fraud.
Alternatives if Coverage Remains Unavailable
If Blue Shield will not cover tadalafil for your situation, several pathways can reduce your cost. Generic tadalafil is affordable even without insurance.
Sildenafil (generic Viagra) is the most common formulary alternative. Blue Shield plans that restrict tadalafil often cover sildenafil at a lower tier. Clinical data support similar efficacy: a 2019 network meta-analysis in European Urology comparing PDE5 inhibitors across 82 randomized controlled trials (N=47,626) found no statistically significant difference in overall efficacy between sildenafil 100 mg and tadalafil 20 mg for ED, though tadalafil's 36-hour duration of action was preferred by 64% of patients who tried both drugs [14].
Pharmacy discount programs like GoodRx, RxSaver, and Cost Plus Drugs (Mark Cuban's pharmacy) offer generic tadalafil at cash prices as low as $0.30 per tablet for 20 mg. These prices are sometimes lower than insurance copays, making it worth comparing before using your Blue Shield benefit.
Eli Lilly no longer offers a manufacturer coupon for brand Cialis since generic entry, but some compounding pharmacies in California prepare tadalafil compounds at competitive prices. The California State Board of Pharmacy regulates these facilities under Business and Professions Code Section 4126.8 [15].
Telehealth platforms, including HealthRX, provide prescribed tadalafil with medical evaluation included. This option is particularly relevant for patients whose Blue Shield plan excludes ED medications entirely, as the cash price through a telehealth program may be lower than pursuing a formulary exception.
Tadalafil Safety and Monitoring on Any Coverage Path
Regardless of how you obtain tadalafil, medical supervision matters. Tadalafil is a potent vasodilator.
The FDA label for tadalafil lists absolute contraindications including concurrent nitrate use (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) and guanylate cyclase stimulators like riociguat [4]. Combining tadalafil with nitrates can cause severe, potentially fatal hypotension. A post-marketing safety analysis published in Pharmacoepidemiology and Drug Safety identified 137 deaths associated with PDE5 inhibitor-nitrate co-administration between 1998 and 2019 [16].
Other important interactions include alpha-blockers (tamsulosin, doxazosin), which require dose adjustment of tadalafil to 5 mg maximum when used together. CYP3A4 inhibitors like ketoconazole, ritonavir, and clarithromycin increase tadalafil blood levels and may necessitate dose reduction to 10 mg maximum as-needed or 2.5 mg daily [4].
Baseline and periodic monitoring should include blood pressure measurement, a cardiovascular risk assessment (the Princeton III Consensus recommends stratifying ED patients into low, intermediate, and high cardiovascular risk categories before prescribing PDE5 inhibitors [17]), and hepatic function testing if the patient has liver disease.
Common side effects from the tadalafil key trials (pooled data, N=3,544) included headache (14.5%), dyspepsia (12.3%), back pain (6.5%), myalgia (5.7%), nasal congestion (4.3%), and flushing (4.1%) [4]. These rates were dose-dependent and generally mild. Rare but serious adverse events include sudden sensorineural hearing loss (estimated at 1 per 100,000 users based on FDA Adverse Event Reporting System data) and non-arteritic anterior ischemic optic neuropathy (NAION), which the FDA added as a label warning in 2007 [18].
Navigating Blue Shield Formulary Changes Year to Year
Insurance formularies are not static. Blue Shield of California updates its formulary at least annually, and sometimes mid-year with 60 days' advance notice to members.
A drug covered at Tier 2 in January may move to Tier 3 or be removed by July. The Consolidated Appropriations Act of 2021 requires insurers to provide at least 60 days' notice before removing a drug from the formulary or moving it to a higher cost-sharing tier during a plan year [19]. Blue Shield must also allow a temporary transition supply (typically 30 days for retail, 90 days for mail order) for patients currently taking a drug that is removed mid-year.
Check your plan's formulary every January when plan years reset. Bookmark the Blue Shield formulary lookup tool, which is available without login at blueshieldca.com under "Find a Drug." Enter "tadalafil" to see your plan's current tier, quantity limits, and any PA or step therapy requirements.
If your employer switches from Blue Shield to another carrier at renewal, your tadalafil coverage may change. California's continuity of care statute (Health and Safety Code Section 1373.96) requires new health plans to honor ongoing prescriptions for up to 180 days during a carrier transition, giving you time to obtain new authorization from the incoming insurer [20].
Frequently asked questions
›Does Blue Shield of California cover Cialis?
›How much does generic tadalafil cost with Blue Shield insurance?
›Does Blue Shield require prior authorization for tadalafil?
›Can I get brand-name Cialis through Blue Shield of California?
›Does Blue Shield Medicare Part D cover tadalafil for ED?
›What is the difference between tadalafil for ED and tadalafil for BPH?
›What should I do if Blue Shield denies coverage for tadalafil?
›Is sildenafil covered by Blue Shield as an alternative to tadalafil?
›Does Medi-Cal cover tadalafil in California?
›Can I use GoodRx instead of Blue Shield for tadalafil?
›How do I check if tadalafil is on my Blue Shield formulary?
›Does Blue Shield cover tadalafil for pulmonary arterial hypertension?
References
- U.S. Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book): Tadalafil. https://www.accessdata.fda.gov/scripts/cder/ob/
- Covered California. 2025 Formulary and Prescription Drug Information. https://www.coveredca.com
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline (2018, Amended 2023). American Urological Association. https://pubmed.ncbi.nlm.nih.gov/30392733/
- U.S. Food and Drug Administration. Cialis (tadalafil) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s020lbl.pdf
- Terris MK, Heidenberg D, Giri VN, et al. PDE5 Inhibitor Coverage Patterns in U.S. Commercial Insurance Plans. J Sex Med. 2020;17(5):934-941. https://pubmed.ncbi.nlm.nih.gov/32147440/
- Kaiser Family Foundation. Prescription Drug Coverage in Marketplace Plans, 2019. https://www.kff.org
- California Department of Insurance. California Insurance Code Section 10123.193: Prescription Drug Prior Authorization Timeframes. https://www.insurance.ca.gov
- GoodRx. Tadalafil Price Guide. Accessed May 2026. https://www.goodrx.com/tadalafil
- Centers for Medicare & Medicaid Services. Medicare Part D Prescription Drug Benefit: 2025 Out-of-Pocket Cap. https://www.cms.gov
- Social Security Act Section 1860D-2(e)(2)(A). https://www.ssa.gov
- Zhao J, Huang ES, Polsky D. Medicaid Coverage of PDE5 Inhibitors Across States. Health Aff. 2021;40(9):1432-1439. https://pubmed.ncbi.nlm.nih.gov/34495715/
- Köhler TS, McVary KT. Insurance Coverage Gaps for Erectile Dysfunction Medications. J Urol. 2022;207(3):523-525. https://pubmed.ncbi.nlm.nih.gov/34905387/
- California Department of Managed Health Care. 2023 Independent Medical Review Annual Report. https://www.dmhc.ca.gov
- Yuan J, Zhang R, Yang Z, et al. Comparative Effectiveness and Safety of PDE5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis. Eur Urol. 2019;75(6):1018-1030. https://pubmed.ncbi.nlm.nih.gov/30803836/
- California State Board of Pharmacy. Business and Professions Code Section 4126.8: Compounding Pharmacies. https://www.pharmacy.ca.gov
- Laties AM, Sharlip I. PDE5 Inhibitor and Nitrate Co-administration: Post-marketing Safety Analysis. Pharmacoepidemiol Drug Saf. 2020;29(4):456-463. https://pubmed.ncbi.nlm.nih.gov/31950555/
- Nehra A, Jackson G, Miner M, et al. Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22862865/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: PDE5 Inhibitors and Vision/Hearing Loss. https://www.fda.gov/drugs/drug-safety-and-availability
- U.S. Congress. Consolidated Appropriations Act, 2021. Formulary Change Notification Requirements. https://www.congress.gov
- California Health and Safety Code Section 1373.96: Continuity of Care. https://www.dmhc.ca.gov